AEMD (AETHLON MEDICAL INC) Stock Analysis - AI Report

AETHLON MEDICAL INC (AEMD) is a publicly traded Healthcare sector company. As of May 21, 2026, AEMD trades at $2.06 with a market cap of $3.20M and a P/E ratio of -0.24. AEMD moved +0.49% today. Year to date, AEMD is -24.73%; over the trailing twelve months it is -93.69%. Its 52-week range spans $1.36 to $84.40. Rallies surfaces AEMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on AEMD?

Rallies AI research for AEMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

AEMD Key Metrics

Key financial metrics for AEMD
MetricValue
Price$2.06
Market Cap$3.20M
P/E Ratio-0.24
EPS$-8.58
Dividend Yield0.00%
52-Week High$84.40
52-Week Low$1.36
Volume2.88K
Avg Volume0
Revenue (TTM)$0
Net Income$-13.39M
Gross Margin0.00%

Latest AEMD News

AEMD Analyst Consensus

AEMD analyst coverage data. Average price target: $0.00.

Common questions about AEMD

What is the AI research view on AEMD?
Rallies AI research for AEMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for AEMD?
Rallies AI research for AEMD combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is AEMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AEMD. It does not provide personalized investment advice.
AEMD

AEMD